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Abstract
Background: For therapeutic usage of induced Pluripotent Stem (iPS) cells, to accomplish xeno-free culture is critical.
Previous reports have shown that human embryonic stem (ES) cells can be maintained in feeder-free condition.
However, absence of feeder cells can be a hostile environment for pluripotent cells and often results in karyotype
abnormalities. Instead of animal feeders, human fibroblasts can be used as feeder cells of human ES cells. However, one
still has to be concerned about the existence of unidentified pathogens, such as viruses and prions in these non-
autologous feeders.
Methodology/Principal Findings: This report demonstrates that human induced Pluripotent Stem (iPS) cells can be
established and maintained on isogenic parental feeder cells. We tested four independent human skin fibroblasts for the
potential to maintain self-renewal of iPS cells. All the fibroblasts tested, as well as their conditioned medium, were capable
of maintaining the undifferentiated state and normal karyotypes of iPS cells. Furthermore, human iPS cells can be generated
on isogenic parental fibroblasts as feeders. These iPS cells carried on proliferation over 19 passages with undifferentiated
morphologies. They expressed undifferentiated pluripotent cell markers, and could differentiate into all three germ layers
via embryoid body and teratoma formation.
Conclusions/Significance: These results suggest that autologous fibroblasts can be not only a source for iPS cells but also
be feeder layers. Our results provide a possibility to solve the dilemma by using isogenic fibroblasts as feeder layers of iPS
cells. This is an important step toward the establishment of clinical grade iPS cells.
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Introduction
Human pluripotent stem cells, both embryonic stem (ES) cells
and induced Pluripotent Stem (iPS) cells, are generally maintained
on mouse embryonic fibroblasts (MEF), which are mitotically
inactivated by treatment with mitomycin C or c-ray irradiation
[1–3]. However, usage of mouse feeder cells may transfer
exogenous antigens, unknown viruses, or zoonotic pathogens to
iPS cells. In fact, non-human sialic acid N-glycolylneuraminic acid
(Neu5Gc), which is potentially immunogenic, was detected on the
surface of human ES cells maintained on MEF feeder [4].
Although feeder-free culture of human ES cells has been reported,
it may lead to chromosomal instabilities of human ES cells [5,6].
To avoid these issues, human fibroblasts from neonatal foreskin or
ES cell-derived fibroblast-like were used to support self-renewal of
human ES cells [7–11]. However, one still have to concern about
existence of unidentified pathogens, such as viruses and prions in
these non-autologous feeders. Since iPS cells are generated from
fibroblasts, it would be ideal if the same fibroblasts can be used for
the generation and maintenance of iPS cells.
Results and Discussion
To examine whether human fibroblasts support self-renewal of
human iPS cells, we treated four independent human fibroblast lines
(1388,1392,1503andNHDF;seeTableS1)andSNLcells[12]with
mitomycin C, and seeded them on culture plates (Fig. S1). Then, we
plated 201B7 iPS cell line [2] derived from 1388 fibroblasts onto
these feeder cells with standard density (1:5 dilutions). The passage
numberofiPScellswas20atthispoint.Allthefivecelllinesoffeeder
cells were supportive for undifferentiated growth of iPS cells at least
19 additional passages (Fig. 1A). The percentage of TRA-1-60 (a
marker for undifferentiated ES cells and iPS cells) positive colonies
was similar among different human fibroblasts and SNL cells
(Fig. 1B). No significant differences were observed in the plating
efficiencies (Fig. 1C). In iPS cells at passage 2 after switching onto
various HDF feeders, no significant re-activation of transgenes was
observed (Fig. S2). In addition, reverse transcription polymerase
chain reaction (RT-PCR) showed that the expression of ES cell
marker genes such as OCT3/4, SOX2 and NANOG were equally to
those of H9 ES cells at passage 19 [1] (Fig. 1D).
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culture of iPS cells. To test whether CM of fibroblasts could
maintain self-renewal of iPS cells without feeder cells, we seeded
201B7 iPS cells onto Matrigel-coated plates in CM from each
human fibroblast line or SNL. As a control, we used non-
conditioned medium supplemented with bFGF. Cells in non-
conditioned medium failed to form tightly packed colonies,
whereas those in each CM grew healthily with typical undiffer-
entiated ES-like morphologies (Fig. S3A). RT-PCR revealed that
iPS cells maintained in each CM expressed undifferentiated ES
cell marker genes such as OCT3/4, SOX2, NANOG and TERT at
similar levels to those in iPS cells or human ES cells cultured on
SNL feeder layers (Fig. S3B). Quantitative PCR (qPCR)
confirmed that no significant alternations in the expression levels
Figure 1. HDF can maintain self-renewal of established human iPS cells. A. Images of iPS cells maintained on each fibroblast at passage
number 10 and 19. Bars indicate 200 mm. B. 201B7 iPS cells at passage number 19 were plated on each feeder, and incubated for 6 days. The graph
shows the percentage of TRA-1-60 positive colonies. Three individual assays were performed. Error bars indicate standard deviation. C. The number of
colonies was counted and compared with the results of SNL feeder. This graph showed the average of three independent experiments. Error bars
mean standard deviation. D. RT-PCR of undifferentiated ES cell markers. 201B7 iPS cells maintained on each HDF over 100 days were lysed, and their
total RNAs were purified. One microgram of RNA sample was used for cDNA synthesis. qPCR was performed with the primers for endogenous OCT3/4,
endogenous SOX2, NANOG and G3PDH. Data were normalized with the value of G3PDH. The graphs showed the average of three experiments. Error
bars indicate standard deviation.
doi:10.1371/journal.pone.0008067.g001
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different feeders (Fig. S3C). These data demonstrated that human
neonatal and adult fibroblasts could be utilized as feeder cells of
human iPS cells.
Next, we examined whether human iPS cells could be
established without non-autologous feeder cells. We introduced
the four reprogramming factors into the four human fibroblast
lines by retroviral transduction. Six days after infection, we plated
the transduced cells at 5610
5 cells on 100-mm dishes either with
SNL feeders, with isogenic human fibroblast feeder, or without
feeder cells. Next day, we started cultivation using human ES cell
culture medium. In the plates without feeders, the plated cells
became confluent within a several days and showed an appearance
resembling feeder cells. Around three weeks after transduction,
ES-like colonies began to emerge on the feeder cell-like layer
(Fig. 2A). We observed no significant differences in the numbers of
ES-like colonies among on SNL feeders, on isogenic fibroblast
feeders or feeder-free condition (Table S2). On day 25 after
transduction, we picked up ES-like colonies from the plates
without feeders and transferred them onto new plates with
mitomycin C-treated each parental fibroblasts as feeders. Human
iPS cells derived from each of the four fibroblast lines used in this
study grew normally and maintained the undifferentiated
morphologies on corresponding autologous feeders for at least
18 passages (Fig. 2B).
RT-PCR showed that established clones at passage number 5
expressed endogenous OCT3/4, SOX2, NANOG and TERT
transcripts at similar levels to those in 201B7 iPS cells, which
were established on SNL feeder cells, and H9 ES cells (Fig. S4A).
The retroviruses of the four factors were effectively silenced,
which is a hallmark of complete reprogramming (Fig. S4B). Even
after additional 15 passages, the expression of OCT3/4, SOX2
and NANOG in these iPS cells were comparable to those of ES
cells and iPS cells maintained on SNL feeder cells (Fig. 2C).
Immunoprecipitation assay with anti-methylated cytosine anti-
body revealed that the promoter regions of pluripotent-associated
genes such as OCT3/4 and NANOG locus were almost completely
unmethylated in iPS cells established and maintained on the
autologous feeders at passage number 5, like in H9 ES cells (Fig.
S5). In addition, iPS cells generated with the autologous feeders
showed normal karyotypes at least after 26 times passages (Fig.
S6).
To evaluate pluripotency of iPS cells generated and maintained
on autologous feeders, we performed in vitro differentiation assay.
These iPS clones formed embryoid bodies using the floating
culture condition. After 16-day differentiation, we detected
SOX17 (endoderm), a-smooth muscle actin (a-SMA, mesoderm)
and NESTIN (ectoderm) positive cells in the culture (Fig. 2D, Fig.
S7). We also confirmed that undifferentiated markers such as
OCT3/4, SOX2 and NANOG decreased and other differentiated
markers such as AFP, PDGFRa and PAX6 increased (Fig. S8). In
addition, we injected iPS cells at passage number 9 into testes of
immune-deficient mice for teratoma formation. After 8 to 12
weeks, all clones we tested developed teratoma containing various
tissues including gut-like epitheliums (endoderm), cartilages
(mesoderm) and neural rosettes (ectoderm) (Fig. 2E). These data
confirmed pluripotency of iPS cells, which were established and
maintained on the autologous feeder cells.
To examine the compatibility of iPS cells and feeder cells, we
plated iPS cells derived from the four HDF onto mitomycin C-
treated parental fibroblasts or SNL cells with all the possible
combinations. After six days, we stained the cells with TRA-1-60
antibody, and counted the number of positive colonies. More than
80% of colonies in all the combinations showed morphology of
undifferentiated ES-like cells and were positive for TRA-1-60 (Fig.
S9).
Our results demonstrated that human iPS cells can be generated
and maintained on autologous fibroblasts as feeder layers.
Furthermore, human iPS cell can be generated even without
any additional feeders, since non-reprogrammed fibroblasts can
serve as feeders. The maintenance of iPS cells can also be achieved
without feeders, by using conditioned medium of human
fibroblasts. All of the tests performed in this study revealed that
iPS cells derived from four independent HDF maintained
autologous feeders kept pluripotency during at least 100 day
culture (Table S3). The most of reprogrammed cell colonies on
isogenic feeders are uniformly undifferentiated (Fig. S9).
In general, we can obtain more than ten millions of fibroblasts
from 5-mm square skin biopsy at the passage number 3 with our
standard protocol [13]. For iPS cell generation with retroviruses,
we need less than 1610
5 fibroblasts. An alternative method using
an episomal vector system requires one million of fibroblasts [14].
Thus, we have enough amounts of surplus fibroblasts to be used as
autologous feeder cells. We did notice that iPS cells cultured on
SNL feeders are easier to passage than those on MEF and human
fibroblast feeders.
Our data that all four HDF lines tested in this study could
support both generation and maintenance of iPS cells, does not
guarantee that every fibroblasts can be used as feeders cells for
human pluripotent cells [15]. We also tested that whether 14 HDF
lines were supportive for maintenance of ES cells and iPS cells.
Both KhES3 ES cell line and 201B7 could grow normally on
eleven out of 14 HDF lines, two MEF lines (ICR and C57BL6)
and SNL [16] (Table S1, Fig. S1). In co-culture with three lines
(1554, 1616 and TIG107), at least either KhES3 or 201B7 could
not stay at undifferentiated state even at passage number 2. At
least, among on 11 supportive fibroblasts and MEF and SNL, no
significant differences were observed in growth rate of ES cells and
iPS cells. Unsupportive lines are indistinguishable from HDF lines
by their morphologies or growth speed. Probably, support activity
for self-renewal of ES cells and iPS cells do not depend on at least
passage number and donor’s sex or race. Unsupportive lines tested
in this study are derived from donors at 68, 77 and 81 years old.
On the other hand, we found that HDF derived from donors at 69
and 73 years old could support maintenance of undifferentiated
state of both ES cells and iPS cells. Further detailed analyses will
be required for decision whether donor’s ages of feeder cells are
important or not.
Recent study by Unger and colleagues demonstrated that iPS
cells derived from human fetal fibroblasts could be established and
maintained on isogenic feeder cells [17]. On the other hand, we
assessed that neonate and adult fibroblast-derived iPS cells can be
generated and maintained on autologous feeders. Inspection of
established iPS cells is always necessary before clinical trials even
in autologous cell transplantation therapy. However, the culture
system established in this study demonstrated that fibroblasts from
an individual could play dual roles as source of iPS cells and feeder
cells, probably contributing to efficient processing for clinical
grade-pluripotent stem cells. Actually, the system still includes
animal components such as albumin, insulin and trypsin. Xeno-
free culture is basically required for therapeutic usage of iPS cells.
However, even if it is for removing the xenogenic components, the
culture condition should not be oppressive for pluripotent cells.
Isogenic culture from the start is one of true worth of iPS cells
because autologous fibroblasts can not normally inhabit when ES
cells are established from blastocysts. Our result is an important
step toward the generation of clinical-grade human iPS cells
suitable for future medical applications.
iPS Cells on Isogenic Feeders
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Cell Culture
Human dermal fibroblasts (HDF) were purchased from Cell
applications Inc or obtained from National Institute of Biomedical
Innovation. HDF, 293FT and PLAT-E [18] were maintained
Dulbecco’s modified eagle medium (DMEM, Nacalai tesque)
contained 10% fetal bovine serum (FBS, Invitrogen) and 0.5%
penicillin and streptomycin (Invitrogen). The medium for human
iPS cells (hES medium) consisted of DMEM/F12 (Invitrogen),
Figure 2. Generation and maintenance of human iPS cells on autologous feeders. A. Images of primary iPS cell colonies. We introduced 4
reprogramming factors into 1388, 1392, 1503 or NHDF. The colonies were photographed 25 days after transduction. Bars indicate 200 mm. B. Images of
established iPS clones. We isolated iPS clones and transferred onto each isogenic fibroblast line. The cells at passage 3 and 18 were photographed. Bars
indicate 200 mm. C. Quantification of the expression of pluripotent stem cell markers. Total RNA of iPS cells established from four independent fibroblast
lines maintained on isogenic feeders, H9 ES cells and HDF was purified, and used for reverse transcription. The graphs show the average of three
independent experiments. Error bars indicate standard deviation. Data were normalized with the results of G3PDH. D. In vitro differentiation of iPS cells.
iPS cells were transferred to suspension culture to form embryoid bodies for 8 days. Embryoid bodies were transferred to gelatin-coated plated, and
incubated another 8 days. Thecells were stainedwith anti-SOX17 (red), anti-a-SMA (red) or anti-NESTIN (green) antibodies. Nucleuses were stained with
Hoechst 33342 (blue). Bars indicate 100 mm. E. Teratoma formation of iPS cells. Paraffin-embedded sections were stained with hematoxylin and eosin.
doi:10.1371/journal.pone.0008067.g002
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glutamine (Invitrogen), 1610
24 M non essential amino acids
(Invitrogen), 1610
24 M 2-mercaptoethanol (Invitrogen) and 0.5%
penicillin and streptomycin supplemented with 4 ng/ml recom-
binant human basic fibroblast growth factor (bFGF, WAKO).
Generation of iPS Cells
iPS cells were established from HDF as described previously
with some slight modifications [2]. In brief, we firstly introduced
mouse solute carrier family 7 (cationic amino acid transporter, y+
system), member 1 (Slc7a1) gene which encodes ecotropic
retrovirus receptor by lentiviral transduction. Transfectants were
plated at 2610
5 cells per 60 mm dish and incubated overnight.
The next day, into the cells OCT3/4, SOX2, KLF4 and c-MYC
were introduced by retroviral infection. Six days later, the cells
were harvested by trypsinization, and plated at 5610
5 cells per
100 mm dish. The medium was replaced on the next day with hES
cell medium, and cultured for another 20 days. At day 25 post-
induction, ES-like colonies were mechanically dissociated and
transferred on to 24-well plate on each isogenic feeder. We
designated this point as passage 1.
Feeder Cells
We added phosphate buffered saline (PBS, Nacalai tesque)
containing 12 mg/ml mitomycin C directly into fibroblast culture
in subconfluent, and incubated at 37uC for 3 hours. After
treatment, the cells were washed twice with PBS and harvested by
trypsinization. The cells were plated at 1610
6 cells per 24-well
plate, 6-well plate, 3 of 60 mm dishes or 100 mm dish.
Conditioned Medium
We plated fibroblasts at 3610
5 cells per 60 mm dish, and
incubated overnight. Next day, the medium was replaced with 3
ml of hES medium, and incubated for 24 hours. After incubation,
the supernatant of fibroblast culture was collected and filtered. We
added 4 ng/ml bFGF before use.
Differentiation
iPS cells were harvested by treatment with CTK solution
consisting of 0.1 mg/ml collagenase IV (Invitrogen), 0.25% trypsin
(Invitrogen), 0.1 mM CaCl2 (Nacalai tesque) and 20% KSR, and
then suspended cell clumps in hES medium plus 10 mM Y-27632
without bFGF [19]. The cells were transferred to ultra low binding
plate (Corning). After 8-day floating culture, embryoid bodies were
transferred on to gelatin-coated plate, and incubated another 8
days. After incubation, the cells were fixed with PBS containing
4% paraformaldehyde and then incubated in PBS containing 5%
normal goat or donkey serum (Chemicon), 1% bovine serum
albumin (BSA, Nacalai tesque), and 0.2% TritonX-100. The
primary antibodies were as follows; anti-SOX17 (1:300, R & D
systems), anti-a-smooth muscle actin (a-SMA, 1:500, DAKO) and
anti-NESTIN (1:1000, Abcam). The secondary antibodies were as
follows; Cyanine 3-labeled anti-goat IgG (1:500, Zymed), Alexa
546-labeled anti-mouse IgG (1:500, Invitrogen) and Alexa 488-
labeled anti-rabbit IgG (1:1000, Invitrogen). Nucleuses were
stained with 1 mg/ml Hoechst 33342 (Invitrogen).
Expression Analyses
We performed RT-PCR as described previously [2]. In brief,
the cells were lysed with Trizol reagent (Invitrogen), and then total
RNA was purified. RNA samples were treated with Turbo DNA
free (Ambion) to remove genomic DNA contamination. One
microgram of DNase treated RNA was used for first-strand
complementary DNA (cDNA) synthesis with Rever tra ace -a-
(Toyobo) and oligo dT20 primer. qPCR was performed using
SYBR Premix ExTaq II (Takara). Primer sequences were listed in
Table S4 [2,20,21,22].
Methylation Assay
Four microgram of genomic DNA was mechanically shared by
sonication, and boiled at 95uC for 10 minutes. Then shared
genomic DNA was incubated with pan-mouse IgG magnetic beads
(Invitrogen) -conjugated anti-5-methyl cytosine antibody (Euro-
gentec) supplemented with 5 mg/ml BSA and 25 mg/ml yeast
tRNA (Ambion) overnight at 4uC. Beads were washed three times
with PBS containing 0.05% TritonX-100. Beads were suspended
in 0.15 ml of TE containing 1% SDS, and incubated at 65uC for 5
minutes. The elution was repeated with an additional 0.15 ml of
1% SDS/TE. The eluates were treated with Protease K at 50uC
for 2 hours, and then extracted with phenol: chloroform: isoamyl
alcohol, and purified by ethanol precipitation. Primer sequences
are provided in Table S4.
Supporting Information
Figure S1 Images of mitomycin C-treated HDF, MEF and SNL.
Bars indicate 200 mm.
Found at: doi:10.1371/journal.pone.0008067.s001 (2.91 MB TIF)
Figure S2 The expression of four reprogramming factors in iPS
cells on various HDF feeders at passage 2. RT-PCR was
performed with the primers for endogenous and total (common
in endogenous and transgene) OCT3/4, SOX2, KLF4 and c-
MYC. Data were normalized with the value of NAT1. The graphs
showed the average of triplicate. Error bars indicate standard
deviation.
Found at: doi:10.1371/journal.pone.0008067.s002 (0.31 MB TIF)
Figure S3 A. Image of 201B7 iPS cells maintained in CM of
each HDF. Bars indicate 200 mm. B. RT-PCR of undifferentiated
ES cell markers. iPS cells maintained on feeders (F) or in feeder-
free culture with conditioned medium (CM) were lysed, and their
total RNAs were purified. One microgram of RNA sample was
used for cDNA synthesis. PCR was performed with the primers for
endogenous OCT3/4, endogenous SOX2, NANOG, TERT and
NAT1. C. qPCR of the expression of OCT3/4, SOX2 and
NANOG in 201B7 iPS cells maintained on various feeder cells or
in their conditioned medium. Data were normalized with the
value of G3PDH. The graphs showed the average of three
experiments. Error bars indicate standard deviation.
Found at: doi:10.1371/journal.pone.0008067.s003 (1.67 MB TIF)
Figure S4 A. RT-PCR of undifferentiated ES cell markers.
Total RNAs of iPS cells established from four independent
fibroblast lines and maintained on each parental fibroblast were
isolated and used for reverse transcription. PCR was performed
with the primers for endogenous OCT3/4, endogenous SOX2,
NANOG, TERT and NAT1. B. The expression of OCT3/4 (total
and endogenous), SOX2 (total and endogenous) and NANOG
were quantified by qPCR. Data were normalized with the value of
G3PDH. The graphs showed the average of triplicate. Error bars
indicate standard deviation.
Found at: doi:10.1371/journal.pone.0008067.s004 (0.75 MB TIF)
Figure S5 CpG methylation statuses at promoter regions of ES
cell marker genes in iPS cells maintained on autologous feeders.
Immunoprecipitants by anti-5-methyl cytosine (mDIP) antibody or
normal mouse IgG, or pre-immunoprecipitated DNA (Input) were
used for qPCR as a template. The data was calculated as (mDIP 2
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ES cells. The data indicate the results of qPCR in triplicate of two
independent experiments. Error bars indicate standard deviation.
Found at: doi:10.1371/journal.pone.0008067.s005 (0.25 MB TIF)
Figure S6 Images of G-band staining of iPS cells.
Found at: doi:10.1371/journal.pone.0008067.s006 (0.68 MB TIF)
Figure S7 Images of differentiated iPS cells in vitro. iPS cells
differentiated via embryoid body formation. Red or green signals
indicate SOX17-, a-SMA- or NESTIN-positive cells. Nucleuses
were stained with Hoechst 33342 (blue). Bars indicate 100 mm.
Found at: doi:10.1371/journal.pone.0008067.s007 (4.63 MB TIF)
Figure S8 iPS cells maintained on isogenic feeders (U) or
differentiated by embryoid body formation (D) were lysed with
Trizol reagent. Total RNA was purified and treated with DNase to
remove genomic DNA contamination. One microgram of DNase-
treated RNA sample was used for first-strand cDNA synthesis with
oligo dT20 primer. PCR was performed with the primers listed in
Supplemental Table 2.
Found at: doi:10.1371/journal.pone.0008067.s008 (0.39 MB TIF)
Figure S9 Images of iPS cells from four HDF on various HDF
feeders or SNL. Red signals indicate TRA-1-60 positive cells.
Nucleuses were visualized by Hoechst 33342 staining. Bars
indicate 200 mm.
Found at: doi:10.1371/journal.pone.0008067.s009 (3.96 MB TIF)
Table S1 The list of HDF lines used in this study.
Found at: doi:10.1371/journal.pone.0008067.s010 (0.04 MB
DOC)
Table S2 The number of ES-like and total colonies from four
HDF on SNL, on isogenic fibroblasts, or in feeder-free condition.
Found at: doi:10.1371/journal.pone.0008067.s011 (0.03 MB
DOC)
Table S3 Experiments performed in this study.
Found at: doi:10.1371/journal.pone.0008067.s012 (0.04 MB
DOC)
Table S4 Primer sequences.
Found at: doi:10.1371/journal.pone.0008067.s013 (0.06 MB
DOC)
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